ArticleClinical and experimental hepatology2024
Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia.
Masahiro Kikuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it